skills.rest
OpenSourcePharmaFoundation
OpenSourcePharmaFoundationCOMMUNITY
Explore all skills by this author →
WebsiteGitHub

combination-designer

Designs rational multi-IO drug combinations mapping compound targets to Oral Mucositis pathways and phases.

4|1|Updated Jan 8, 2024
Search Tags:#drug repurposing#network pharmacology#oral mucositis#combination design#synergy assessment#Ayurvedic formulations
One-click install
npx skills add https://github.com/OpenSourcePharmaFoundation/ospf-ayurveda-kg --skill combination-designer
Or copy as Structured Prompt for Agent▼
Please help me install this Agent Skill.
Skill: combination-designer
Source: https://github.com/OpenSourcePharmaFoundation/ospf-ayurveda-kg/tree/main/.claude/skills/combination-designer
Command: npx skills add https://github.com/OpenSourcePharmaFoundation/ospf-ayurveda-kg --skill combination-designer

SYSTEM DOCUMENTATION & REQUIREMENTS

What problem does it solve?

It helps you design multi-compound treatment strategies for Oral Mucositis (OM) by evaluating synergy, pathway coverage, and cancer-therapy compatibility instead of guessing from single-agent evidence.

Core Features & Use Cases

  • Rational multi-compound design: Build 2–4 component combinations that map to OM pathways and phases, including Ayurvedic multi-ingredient logic.
  • Synergy and conflict assessment: Analyze target overlap, pathway convergence, sequential blockade ideas, and potential antagonistic or DDI risks (CYP, target competition, protein binding displacement).
  • Formulation and safety guardrails: Check practical delivery feasibility (e.g., rinse vs gel), stability/compatibility considerations, and guard against interfering with chemotherapy.

Quick Start

Ask the AI to propose a 2–4 component combination for OM, then return a full synergy report with target overlap, pathway/phase coverage, DDI risk, formulation feasibility, and a verdict.

Frequently Asked Questions about combination-designer

High-intent search queries and answers about installing and using this skill.

FAQPage Schema
How do I design a rational drug combination for oral mucositis?▼

Design rational drug combinations for oral mucositis by mapping compound targets to OM pathways and phases, analyzing synergy, and screening for chemotherapy compatibility to produce a structured combination report.

What is synergy assessment in multi-compound drug repurposing?▼

Synergy assessment in multi-compound drug repurposing evaluates target overlap, pathway convergence, and sequential blockade to identify potential antagonistic risks or drug-drug interactions across 2–4 component combinations.

Can I use Ayurvedic formulations in oral mucositis combination design?▼

You can use Ayurvedic formulations in oral mucositis combination design by applying multi-ingredient logic to map active compound targets against OM pathways and evaluate formulation feasibility.

How do I check for pathway coverage gaps in oral mucositis treatment?▼

Check for pathway coverage gaps in oral mucositis treatment by analyzing available project processed data to map compound targets against OM pathways and identify unaddressed therapeutic phases.

Does oral mucositis combination design work with cancer chemotherapy constraints?▼

Oral mucositis combination design works with cancer chemotherapy constraints by applying guardrails to prevent interference with chemotherapy regimens and screening for CYP interactions and target competition.

What are the limitations of network pharmacology for drug combination design?▼

Limitations of network pharmacology for drug combination design include the need for pre-processed target data, reliance on theoretical pathway mapping, and the necessity of separate validation for formulation stability.

Related Skills

Explore More Education & Research Skills→
OpenSourcePharmaFoundationOpenSourcePharmaFoundation
4

pathway-analyst

Convert drug and phytochemical target evidence into OM-specific signaling pathway maps and vulnerability assessments.

Community
Advanced
hummbl-devhummbl-dev
2

transformation-workflow

Automates step-by-step workflows for HUMMBL's six transformation models.

Community
Basic
OpenSourcePharmaFoundationOpenSourcePharmaFoundation
4

drug-repurposing-strategist

Match OM-associated genes to approved drug targets and rank repurposing candidates.

Community
Advanced
OpenSourcePharmaFoundationOpenSourcePharmaFoundation
4

natural-product-scout

Screen PubChem and ChemBL datasets for phytochemicals targeting OM-relevant proteins.

Community
Intermediate